292 related articles for article (PubMed ID: 20634197)
1. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.
Canzian F; Cox DG; Setiawan VW; Stram DO; Ziegler RG; Dossus L; Beckmann L; Blanché H; Barricarte A; Berg CD; Bingham S; Buring J; Buys SS; Calle EE; Chanock SJ; Clavel-Chapelon F; DeLancey JO; Diver WR; Dorronsoro M; Haiman CA; Hallmans G; Hankinson SE; Hunter DJ; Hüsing A; Isaacs C; Khaw KT; Kolonel LN; Kraft P; Le Marchand L; Lund E; Overvad K; Panico S; Peeters PH; Pollak M; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Yeager M; Hoover RN; Riboli E; Thomas G; Henderson BE; Kaaks R; Feigelson HS
Hum Mol Genet; 2010 Oct; 19(19):3873-84. PubMed ID: 20634197
[TBL] [Abstract][Full Text] [Related]
2. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Patel AV; Cheng I; Canzian F; Le Marchand L; Thun MJ; Berg CD; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Cox DG; Dorronsoro M; Dossus L; Haiman CA; Hankinson SE; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Linseisen J; Lund E; Manjer J; McCarty C; Peeters PH; Pike MC; Pollak M; Riboli E; Stram DO; Tjonneland A; Travis RC; Trichopoulos D; Tumino R; Yeager M; Ziegler RG; Feigelson HS;
PLoS One; 2008 Jul; 3(7):e2578. PubMed ID: 18596909
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of common IGF1, IGFBP1 and IGFBP3 genetic variation with prospective IGF-I and IGFBP-3 blood levels and prostate cancer risk among Caucasians.
Schumacher FR; Cheng I; Freedman ML; Mucci L; Allen NE; Pollak MN; Hayes RB; Stram DO; Canzian F; Henderson BE; Hunter DJ; Virtamo J; Manjer J; Gaziano JM; Kolonel LN; Tjønneland A; Albanes D; Calle EE; Giovannucci E; Crawford ED; Haiman CA; Kraft P; Willett WC; Thun MJ; Le Marchand L; Kaaks R; Feigelson HS; Bueno-de-Mesquita HB; Palli D; Riboli E; Lund E; Amiano P; Andriole G; Dunning AM; Trichopoulos D; Stampfer MJ; Key TJ; Ma J
Hum Mol Genet; 2010 Aug; 19(15):3089-101. PubMed ID: 20484221
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium.
Barrdahl M; Canzian F; Gaudet MM; Gapstur SM; Trichopoulou A; Tsilidis K; van Gils CH; Borgquist S; Weiderpass E; Khaw KT; Giles GG; Milne RL; Le Marchand L; Haiman C; Lindström S; Kraft P; Hunter DJ; Ziegler R; Chanock SJ; Yang XR; Buring JE; Lee IM; Kaaks R; Campa D
Int J Cancer; 2018 Mar; 142(6):1182-1188. PubMed ID: 29114882
[TBL] [Abstract][Full Text] [Related]
5. CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.
Travis RC; Schumacher F; Hirschhorn JN; Kraft P; Allen NE; Albanes D; Berglund G; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Calle EE; Chanock S; Dunning AM; Hayes R; Feigelson HS; Gaziano JM; Giovannucci E; Haiman CA; Henderson BE; Kaaks R; Kolonel LN; Ma J; Rodriguez L; Riboli E; Stampfer M; Stram DO; Thun MJ; Tjønneland A; Trichopoulos D; Vineis P; Virtamo J; Le Marchand L; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2734-44. PubMed ID: 19789370
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor pathway genes and blood concentrations, dietary protein and risk of prostate cancer in the NCI Breast and Prostate Cancer Cohort Consortium (BPC3).
Tsilidis KK; Travis RC; Appleby PN; Allen NE; Lindström S; Albanes D; Ziegler RG; McCullough ML; Siddiq A; Barricarte A; Berndt SI; Bueno-de-Mesquita HB; Chanock SJ; Crawford ED; Diver WR; Gapstur SM; Giovannucci E; Gu F; Haiman CA; Hayes RB; Hunter DJ; Johansson M; Kaaks R; Kolonel LN; Kraft P; Le Marchand L; Overvad K; Polidoro S; Riboli E; Schumacher FR; Stevens VL; Trichopoulos D; Virtamo J; Willett WC; Key TJ
Int J Cancer; 2013 Jul; 133(2):495-504. PubMed ID: 23341348
[TBL] [Abstract][Full Text] [Related]
7. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer.
Gu F; Schumacher FR; Canzian F; Allen NE; Albanes D; Berg CD; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Buring JE; Chabbert-Buffet N; Chanock SJ; Clavel-Chapelon F; Dumeaux V; Gaziano JM; Giovannucci EL; Haiman CA; Hankinson SE; Hayes RB; Henderson BE; Hunter DJ; Hoover RN; Johansson M; Key TJ; Khaw KT; Kolonel LN; Lagiou P; Lee IM; LeMarchand L; Lund E; Ma J; Onland-Moret NC; Overvad K; Rodriguez L; Sacerdote C; Sánchez MJ; Stampfer MJ; Stattin P; Stram DO; Thomas G; Thun MJ; Tjønneland A; Trichopoulos D; Tumino R; Virtamo J; Weinstein SJ; Willett WC; Yeager M; Zhang SM; Kaaks R; Riboli E; Ziegler RG; Kraft P
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2877-87. PubMed ID: 20810604
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of hormone and genetic variation in 36 genes related to steroid hormone metabolism in pre- and postmenopausal women from the breast and prostate cancer cohort consortium (BPC3).
Beckmann L; Hüsing A; Setiawan VW; Amiano P; Clavel-Chapelon F; Chanock SJ; Cox DG; Diver R; Dossus L; Feigelson HS; Haiman C; Hallmans G; Hayes RB; Henderson BE; Hoover RN; Hunter DJ; Khaw K; Kolonel LN; Kraft P; Lund E; Le Marchand L; Peeters PH; Riboli E; Stram D; Thomas G; Thun MJ; Tumino R; Trichopoulos D; Vogel U; Willett WC; Yeager M; Ziegler R; Hankinson SE; Kaaks R;
J Clin Endocrinol Metab; 2011 Feb; 96(2):E360-7. PubMed ID: 21177793
[TBL] [Abstract][Full Text] [Related]
9. CYP17 genetic variation and risk of breast and prostate cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Setiawan VW; Schumacher FR; Haiman CA; Stram DO; Albanes D; Altshuler D; Berglund G; Buring J; Calle EE; Clavel-Chapelon F; Cox DG; Gaziano JM; Hankinson SE; Hayes RB; Henderson BE; Hirschhorn J; Hoover R; Hunter DJ; Kaaks R; Kolonel LN; Kraft P; Ma J; Le Marchand L; Linseisen J; Lund E; Navarro C; Overvad K; Palli D; Peeters PH; Pike MC; Riboli E; Stampfer MJ; Thun MJ; Travis R; Trichopoulos D; Yeager M; Ziegler RG; Spencer Feigelson H; Chanock SJ
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2237-46. PubMed ID: 18006912
[TBL] [Abstract][Full Text] [Related]
10. Interactions between genome-wide significant genetic variants and circulating concentrations of insulin-like growth factor 1, sex hormones, and binding proteins in relation to prostate cancer risk in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Tsilidis KK; Travis RC; Appleby PN; Allen NE; Lindstrom S; Schumacher FR; Cox D; Hsing AW; Ma J; Severi G; Albanes D; Virtamo J; Boeing H; Bueno-de-Mesquita HB; Johansson M; Quirós JR; Riboli E; Siddiq A; Tjønneland A; Trichopoulos D; Tumino R; Gaziano JM; Giovannucci E; Hunter DJ; Kraft P; Stampfer MJ; Giles GG; Andriole GL; Berndt SI; Chanock SJ; Hayes RB; Key TJ
Am J Epidemiol; 2012 May; 175(9):926-35. PubMed ID: 22459122
[TBL] [Abstract][Full Text] [Related]
11. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
[TBL] [Abstract][Full Text] [Related]
12. A large study of androgen receptor germline variants and their relation to sex hormone levels and prostate cancer risk. Results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
Lindström S; Ma J; Altshuler D; Giovannucci E; Riboli E; Albanes D; Allen NE; Berndt SI; Boeing H; Bueno-de-Mesquita HB; Chanock SJ; Dunning AM; Feigelson HS; Gaziano JM; Haiman CA; Hayes RB; Henderson BE; Hunter DJ; Kaaks R; Kolonel LN; Le Marchand L; Martínez C; Overvad K; Siddiq A; Stampfer M; Stattin P; Stram DO; Thun MJ; Trichopoulos D; Tumino R; Virtamo J; Weinstein SJ; Yeager M; Kraft P; Freedman ML
J Clin Endocrinol Metab; 2010 Sep; 95(9):E121-7. PubMed ID: 20534771
[TBL] [Abstract][Full Text] [Related]
13. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Dossus L; Kaaks R; Canzian F; Albanes D; Berndt SI; Boeing H; Buring J; Chanock SJ; Clavel-Chapelon F; Feigelson HS; Gaziano JM; Giovannucci E; Gonzalez C; Haiman CA; Hallmans G; Hankinson SE; Hayes RB; Henderson BE; Hoover RN; Hunter DJ; Khaw KT; Kolonel LN; Kraft P; Ma J; Le Marchand L; Lund E; Peeters PH; Stampfer M; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D; Tumino R; Riboli E; Virtamo J; Weinstein SJ; Yeager M; Ziegler RG; Cox DG
Carcinogenesis; 2010 Mar; 31(3):455-61. PubMed ID: 19965896
[TBL] [Abstract][Full Text] [Related]
14. Haplotypes of the estrogen receptor beta gene and breast cancer risk.
; Cox DG; Bretsky P; Kraft P; Pharoah P; Albanes D; Altshuler D; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Calle EE; Canzian F; Chanock S; Clavel-Chapelon F; Colditz GA; Feigelson HS; Haiman CA; Hankinson SE; Hirschhorn J; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; LeMarchand L; Lund E; Palli D; Peeters PH; Pike MC; Riboli E; Stram DO; Thun M; Tjonneland A; Travis RC; Trichopoulos D; Yeager M
Int J Cancer; 2008 Jan; 122(2):387-92. PubMed ID: 17935138
[TBL] [Abstract][Full Text] [Related]
15. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).
Canzian F; Kaaks R; Cox DG; Henderson KD; Henderson BE; Berg C; Bingham S; Boeing H; Buring J; Calle EE; Chanock S; Clavel-Chapelon F; Dossus L; Feigelson HS; Haiman CA; Hankinson SE; Hoover R; Hunter DJ; Isaacs C; Lenner P; Lund E; Overvad K; Palli D; Pearce CL; Quiros JR; Riboli E; Stram DO; Thomas G; Thun MJ; Trichopoulos D; van Gils CH; Ziegler RG
BMC Cancer; 2009 Jul; 9():257. PubMed ID: 19640273
[TBL] [Abstract][Full Text] [Related]
17. Single and multigenic analysis of the association between variants in 12 steroid hormone metabolism genes and risk of prostate cancer.
Beuten J; Gelfond JA; Franke JL; Weldon KS; Crandall AC; Johnson-Pais TL; Thompson IM; Leach RJ
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1869-80. PubMed ID: 19505920
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.
Cao Y; Lindström S; Schumacher F; Stevens VL; Albanes D; Berndt S; Boeing H; Bueno-de-Mesquita HB; Canzian F; Chamosa S; Chanock SJ; Diver WR; Gapstur SM; Gaziano JM; Giovannucci EL; Haiman CA; Henderson B; Johansson M; Le Marchand L; Palli D; Rosner B; Siddiq A; Stampfer M; Stram DO; Tamimi R; Travis RC; Trichopoulos D; Willett WC; Yeager M; Kraft P; Hsing AW; Pollak M; Lin X; Ma J
J Natl Cancer Inst; 2014 Jun; 106(6):dju085. PubMed ID: 24824313
[TBL] [Abstract][Full Text] [Related]
19. The impact of common genetic variations in genes of the sex hormone metabolic pathways on steroid hormone levels and prostate cancer aggressiveness.
Sun T; Oh WK; Jacobus S; Regan M; Pomerantz M; Freedman ML; Lee GS; Kantoff PW
Cancer Prev Res (Phila); 2011 Dec; 4(12):2044-50. PubMed ID: 21900597
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the HSD17B1 gene and risk of prostate cancer.
Kraft P; Pharoah P; Chanock SJ; Albanes D; Kolonel LN; Hayes RB; Altshuler D; Andriole G; Berg C; Boeing H; Burtt NP; Bueno-de-Mesquita B; Calle EE; Cann H; Canzian F; Chen YC; Crawford DE; Dunning AM; Feigelson HS; Freedman ML; Gaziano JM; Giovannucci E; Gonzalez CA; Haiman CA; Hallmans G; Henderson BE; Hirschhorn JN; Hunter DJ; Kaaks R; Key T; Le Marchand L; Ma J; Overvad K; Palli D; Pike MC; Riboli E; Rodriguez C; Setiawan WV; Stampfer MJ; Stram DO; Thomas G; Thun MJ; Travis R; Trichopoulou A; Virtamo J; Wacholder S
PLoS Genet; 2005 Nov; 1(5):e68. PubMed ID: 16311626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
